L. F. Gram

CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages

Julia Kirchheiner, Kim Brøsen, Marja­‐Liisa Dahl et al. · Acta Psychiatrica Scandinavica · 2001 · 422 citations

Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention

Jesper Hallas, B Harvald, L. F. Gram et al. · Journal of Internal Medicine · 1990 · 374 citations

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

K. Br�sen, L. F. Gram · European Journal of Clinical Pharmacology · 1989 · 285 citations

Mendelian Disorder, Sparteine/debrisoquine Oxidation Polymorphism, Genetics +4

Pharmacokinetics of Citalopram in Relation to the Sparteine and the Mephenytoin Oxidation Polymorphisms

Søren H. Sindrup, Kim Brøsen, M. G. J. Hansen et al. · Therapeutic Drug Monitoring · 1993 · 215 citations

Pharmacotherapy, Drug Resistance, Medicinal Chemistry +16

Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment

M. L. Friis, O. Kristensen, J. Boas et al. · Acta Neurologica Scandinavica · 2009 · 202 citations

Drug Safety, Psychiatry, Elderly Patients +14